Price
CHART BY
Frequently asked questions
What is Neogen's market capitalization?
The market capitalization of Neogen is $2.61B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Neogen?
Neogen's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.109. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Neogen's stock?
Currently, 4 analysts cover Neogen's stock, with a consensus target price of $16.17. Analyst ratings provide insights into the stock's expected performance.
What is Neogen's revenue over the trailing twelve months?
Over the trailing twelve months, Neogen reported a revenue of $912.20M.
What is the EBITDA for Neogen?
Neogen's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $176.62M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Neogen?
Neogen has a free cash flow of -$125.42M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Neogen have, and what sector and industry does it belong to?
Neogen employs approximately 2,917 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Neogen's shares?
The free float of Neogen is 216.15M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $2.61B
- EPS (TTM)
- -$0.109
- Free Float
- 216.15M
- Revenue (TTM)
- $912.20M
- EBITDA (TTM)
- $176.62M
- Free Cashflow (TTM)
- -$125.42M
Pricing
- 1D span
- $11.74$12.21
- 52W span
- $11.47$20.75
Analyst Ratings
The price target is $16.17 and the stock is covered by 4 analysts.
Buy
2
Hold
2
Sell
0
Information
Neogen Corp. engages in the provision of development, manufacture, and marketing of food and animal safety products. It operates through the Food Safety and Animal Safety segments. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.
- Employees
- 2,917
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US6404911066
- Primary Ticker
- NEOG